Kyriz Pharmaceuticals Private Limited
About Kyriz Pharmaceuticals Private Limited
Data last updated:
Kyriz Pharmaceuticals Private Limited is a private limited company based in Panchkula, Haryana, India. It was incorporated on 14 March 2023.
The company is registered with the Registrar of Companies (ROC), Haryana, under CIN U46497HR2023PTC109903. Its GSTIN is 06AAKCK0833E1ZT (Haryana).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Neha and Harish Dua.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Hb 367 Ms 1362, Village Fatehpur Sector – 20 Panchkula, Haryana, India – 134112.
As per the financials filed for FY 2024, the company reported a revenue of ₹64.74 Lakh. For the same year it recorded a net profit of ₹41,973 (net margin 0.6%) and EBITDA of ₹66,096 (EBITDA margin 1%).
Company details
Contact details
Kyriz Pharmaceuticals Private Limited's registered office is in Panchkula, Haryana.
- Registered AddressHb 367 Ms 1362, Village Fatehpur Sector – 20 Panchkula, Haryana, India – 134112
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Kyriz Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Kyriz Pharmaceuticals Private Limited, buy the company report.
Financials of Kyriz Pharmaceuticals Private Limited
FY 2025 filings availableKyriz Pharmaceuticals Private Limited reported revenue of ₹64.74 Lakh for FY 2024.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | ₹66,096 | |
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | ₹41,973 | |
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | 1% | |
| Net Profit Margin | 0.6% | |
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Kyriz Pharmaceuticals Private Limited, buy the company report.
Board of directors of Kyriz Pharmaceuticals Private Limited
Kyriz Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Neha | Director | 14 Mar 2023 | 3 Years 7 Months | Current |
| Harish Dua | Director | 14 Mar 2023 | 3 Years 7 Months | Current |
Peer comparison
Kyriz Pharmaceuticals Private Limited is compared with the 8 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Victro Pharmaceuticals Private Limited | ₹65.24 Lakh (FY 2025) | -30.0% | New Delhi, Delhi, India | |||
| Akon Pharmaceuticals Private Limited | ₹65.2 Lakh (FY 2024) | 196.0% | Surat, Gujarat, India | |||
| Zecon Pharmaceuticals Private Limited | ₹65.17 Lakh (FY 2024) | -77.0% | Lucknow, Uttar Pradesh, India | |||
| Aironax Pharmaceuticals Private Limited | ₹65.15 Lakh (FY 2025) | 138.0% | Vadodara, Gujarat, India | |||
| Almonds Pharmaceuticals Private Limited | ₹65.07 Lakh (FY 2021) | 5.0% | Kolar, Karnataka, India | |||
| Kyriz Pharmaceuticals Private Limitedthis company | ₹64.74 Lakh (FY 2024) | ₹41,973 | 0.6% | Panchkula, Haryana, India | ||
| Novokon Pharmaceuticals Private Limited | ₹64.59 Lakh (FY 2025) | -45.0% | Greater Noida, Uttar Pradesh, India | |||
| Organic Pharmaceuticals Private Limited | ₹64.39 Lakh (FY 2025) | 16.0% | New Delhi, Delhi, India | |||
| M.T Pharmaceuticals Private Limited | ₹64.22 Lakh (FY 2025) | -24.0% | Gorakhpur, Uttar Pradesh, India |
To see the full peer comparison of Kyriz Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Kyriz Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Kyriz Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Kyriz Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 06AAKCK0833E1ZT | Haryana | Active | 03 Apr 2023 |
To see the full GST registrations and return filing status of Kyriz Pharmaceuticals Private Limited, buy the company report.
Recent activity
Kyriz Pharmaceuticals Private Limited has 2 board changes on record since 2023: 2 appointments. The latest: Harish Dua was appointed as Director on 14 Mar 2023.
Frequently asked questions
Kyriz Pharmaceuticals is an active private limited company based in Panchkula, Haryana, India. It was incorporated on 14 March 2023 (3+ years old) and is registered under CIN U46497HR2023PTC109903.
Kyriz Pharmaceuticals has 2 current directors:
- Neha - Director
- Harish Dua - Director
The latest financial statements of Kyriz Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2023 are in the company report.
The GSTIN of Kyriz Pharmaceuticals is 06AAKCK0833E1ZT, registered in Haryana.
The CIN (Corporate Identification Number) of Kyriz Pharmaceuticals is U46497HR2023PTC109903. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Kyriz Pharmaceuticals was incorporated on 14 March 2023, making it 3+ years old. It is registered with the Registrar of Companies, Haryana.
The peers of Kyriz Pharmaceuticals by revenue are Victro Pharmaceuticals Private Limited, Akon Pharmaceuticals Private Limited, Zecon Pharmaceuticals Private Limited, Aironax Pharmaceuticals Private Limited, Almonds Pharmaceuticals Private Limited and 3 more, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Harish Dua was appointed as Director on 14 Mar 2023. Neha was appointed as Director on 14 Mar 2023.
The registered office of Kyriz Pharmaceuticals is at Hb 367 Ms 1362, Village Fatehpur Sector – 20 Panchkula, Haryana, India – 134112.
Kyriz Pharmaceuticals can be reached at its registered office: Hb 367 Ms 1362, Village Fatehpur Sector – 20 Panchkula, Haryana, India – 134112.
Kyriz Pharmaceuticals is registered under the jurisdiction of the Registrar of Companies (ROC), Haryana.